{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:26:16Z","timestamp":1791919576942,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012283","name":"Chiayi Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.drugalcdep.2020.108495","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T19:52:35Z","timestamp":1609444355000},"page":"108495","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Selective serotonin reuptake inhibitors use and hepatocellular carcinoma in patients with alcohol use disorder"],"prefix":"10.1016","volume":"219","author":[{"given":"Vincent Chin-Hung","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0269-8743","authenticated-orcid":false,"given":"Min-Jing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8080-0504","authenticated-orcid":false,"given":"Yao-Hsu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mong-Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Che","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7522-3677","authenticated-orcid":false,"given":"Michael E.","family":"Dewey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.108495_bib0005","first-page":"CD008581","article-title":"Antidepressants for the treatment of people with co-occurring depression and alcohol dependence","volume":"4","author":"Agabio","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2020.108495_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-3-319-67591-6_15","article-title":"Targeting TCTP with sertraline and thioridazine in cancer treatment","volume":"64","author":"Amson","year":"2017","journal-title":"Results Probl. Cell Differ."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108495_bib0015","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/1535370213493721","article-title":"Antidepressant drugs as a complementary therapeutic strategy in cancer","volume":"238","author":"Bielecka","year":"2013","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108495_bib0020","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1360-0443.2010.03351.x","article-title":"Alcohol and depression","volume":"106","author":"Boden","year":"2011","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108495_bib0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pon.4493","article-title":"SSRIs associated with decreased risk of hepatocellular carcinoma: a population-based case-control study","volume":"27","author":"Chan","year":"2018","journal-title":"Psychooncology"},{"key":"10.1016\/j.drugalcdep.2020.108495_bib0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2147\/CMAR.S148097","article-title":"Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients","volume":"9","author":"Chang","year":"2017","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108495_bib0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/toxsci\/kft254","article-title":"Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway","volume":"137","author":"Chen","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"18","key":"10.1016\/j.drugalcdep.2020.108495_bib0040","doi-asserted-by":"crossref","first-page":"30464","DOI":"10.18632\/oncotarget.12826","article-title":"Hepatocellular carcinoma and antidepressants: a nationwide population-based study","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.drugalcdep.2020.108495_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jad.2019.04.093","article-title":"Antidepressant use and hepatocellular carcinoma in patients with hepatitis C who had received interferon therapy: a population-based cohort study","volume":"253","author":"Chen","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108495_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030757","article-title":"Fluoxetine induces apoptosis through extrinsic\/intrinsic pathways and inhibits ERK\/NF-kappaB-modulated anti-apoptotic and invasive potential in hepatocellular carcinoma cells in vitro","volume":"20","author":"Chen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.drugalcdep.2020.108495_bib0055","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1371\/journal.pmed.0050141","article-title":"Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys","volume":"5","author":"Degenhardt","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.drugalcdep.2020.108495_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jad.2015.06.024","article-title":"Depression in patients with alcohol use disorders: systematic review and meta-analysis of outcomes for independent and substance-induced disorders","volume":"185","author":"Foulds","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108495_bib0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","article-title":"Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine","volume":"68","author":"Fujiwara","year":"2018","journal-title":"J. Hepatol."},{"issue":"23","key":"10.1016\/j.drugalcdep.2020.108495_bib0070","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1200\/JCO.2013.49.5283","article-title":"Challenges of guarantee-time bias","volume":"31","author":"Giobbie-Hurder","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.drugalcdep.2020.108495_bib0075","doi-asserted-by":"crossref","first-page":"110054","DOI":"10.1016\/j.biopha.2020.110054","article-title":"Beneficial effect of fluoxetine on anti-tumor progression on hepatocellular carcinoma and non-small cell lung cancer bearing animal model","volume":"126","author":"Hsu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2020.108495_bib0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jad.2020.01.141","article-title":"Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990-2019: systematic review and meta-analysis","volume":"266","author":"Hunt","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108495_bib0085","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/jcmm.14011","article-title":"Anticancer activity of paroxetine in human colon cancer cells: involvement of MET and ERBB3","volume":"23","author":"Jang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108495_bib0090","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cld.2016.02.012","article-title":"Alcoholic liver disease: high risk or low risk for developing hepatocellular carcinoma?","volume":"20","author":"Joshi","year":"2016","journal-title":"Clin. Liver Dis. (Hoboken)"},{"issue":"7","key":"10.1016\/j.drugalcdep.2020.108495_bib0095","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/add.14935","article-title":"Effect of alcohol use disorders and alcohol intake on the risk of subsequent depressive symptoms: a systematic review and meta-analysis of cohort studies","volume":"115","author":"Li","year":"2020","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108495_bib0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/01480545.2012.710625","article-title":"Effect of sertraline on [Ca2+](i) and viability of human MG63 osteosarcoma cells","volume":"36","author":"Lin","year":"2013","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.drugalcdep.2020.108495_bib0105","doi-asserted-by":"crossref","first-page":"e2018062","DOI":"10.4178\/epih.e2018062","article-title":"Data resource profile: the national health insurance research database (NHIRD)","volume":"40","author":"Lin","year":"2018","journal-title":"Epidemiol. Health"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108495_bib0110","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3892\/or.2016.4860","article-title":"Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells","volume":"36","author":"Ma","year":"2016","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108495_bib0115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jhep.2004.10.005","article-title":"Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma","volume":"42","author":"Marrero","year":"2005","journal-title":"J. Hepatol."},{"issue":"5 Suppl. 1","key":"10.1016\/j.drugalcdep.2020.108495_bib0120","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1053\/j.gastro.2004.09.020","article-title":"Alcohol and hepatocellular carcinoma","volume":"127","author":"Morgan","year":"2004","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108495_bib0125","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/apt.12925","article-title":"Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation","volume":"40","author":"Mullish","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108495_bib0130","first-page":"3691","article-title":"Fluoxetine-induced apoptosis in hepatocellular carcinoma cells","volume":"33","author":"Mun","year":"2013","journal-title":"Anticancer Res."},{"issue":"15","key":"10.1016\/j.drugalcdep.2020.108495_bib0135","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.291.15.1887","article-title":"Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis","volume":"291","author":"Nunes","year":"2004","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.108495_bib0140","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/add.14234","article-title":"Global statistics on alcohol, tobacco and illicit drug use: 2017 status report","volume":"113","author":"Peacock","year":"2018","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108495_bib0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","article-title":"Constructing a control group using multivariate matched sampling methods that incorporate the propensity score","volume":"39","author":"Rosenbaum","year":"1985","journal-title":"Am. Statist."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108495_bib0150","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood-2002-07-2044","article-title":"Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells","volume":"101","author":"Serafeim","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108495_bib0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108495_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.09.004","article-title":"Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis","volume":"78","author":"Torrens","year":"2005","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.drugalcdep.2020.108495_bib0165","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2012.44.6831","article-title":"Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection","volume":"31","author":"Tsan","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108495_bib0170","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/annonc\/mdu020","article-title":"Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies","volume":"25","author":"Turati","year":"2014","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108495_bib0175","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1176\/appi.ajp.2013.13050709","article-title":"Antidepressant-induced liver injury: a review for clinicians","volume":"171","author":"Voican","year":"2014","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108495_bib0180","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2015.07.006","article-title":"Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection","volume":"63","author":"Yang","year":"2015","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.108495_bib0185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108495_bib0190","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.25670","article-title":"Fibrosis-dependent mechanisms of hepatocarcinogenesis","volume":"56","author":"Zhang","year":"2012","journal-title":"Hepatology"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620306608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620306608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T22:29:33Z","timestamp":1732314573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620306608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":38,"alternative-id":["S0376871620306608"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108495","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective serotonin reuptake inhibitors use and hepatocellular carcinoma in patients with alcohol use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108495","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108495"}}